Position in EVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$217,950
+$3,844 QoQ
Shares Held
87,180
+25.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
9,668,611 | $237,944,516 | |
| 2 | ZTS |
Zoetis Inc.
|
3,188,263 | $229,108,578 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
304,692 | $165,091,266 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
1,376,480 | $152,706,691 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,667,827 | $109,460,941 | |
| 6 | ALKS |
Alkermes plc.
|
1,645,101 | $86,203,291 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,373,982 | $63,903,902 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
846,936 | $29,363,271 |
All Filings in EVO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,950 | 87,180 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $214,106 | 69,515 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $348,643 | 96,045 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $141,010 | 33,574 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $100,229 | 27,460 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $54,931 | 11,444 | Shares | Defined | 2024-08-14 | |
| 2023-09-30 | $254,191 | 25,754 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $152,550 | 13,500 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $107,467 | 13,284 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||